These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3727396)

  • 1. [Adsorbed subunit influenza vaccine: its isolation and characteristics].
    Shapiro NI; Zhukova TIa; Shpiliuk GF; Entina NN; Konstantinov VK
    Virologie; 1986; 37(2):125-9. PubMed ID: 3727396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Subvirion influenza vaccines: a subunit (glycoprotein) trivalent preparation Grippovac SE-AZh for immunization against influenza in children and persons with chronic pathology].
    Chumakov MP; Mel'nikova SK; Kusov IuIu; Kochetkov NK; Derevitskaia VA
    Vestn Akad Med Nauk SSSR; 1983; (12):21-9. PubMed ID: 6666316
    [No Abstract]   [Full Text] [Related]  

  • 3. [Preparation of an influenza vaccine from allantoic viral cultures inactivated with UV irradiation].
    Polianskaia NIu
    Tr Inst Im Pastera; 1979; 52():107-10. PubMed ID: 550532
    [No Abstract]   [Full Text] [Related]  

  • 4. [Live influenza vaccine].
    Smorodintsev AA
    Vestn Akad Med Nauk SSSR; 1983; (12):15-21. PubMed ID: 6666315
    [No Abstract]   [Full Text] [Related]  

  • 5. [Laboratory control of the purity of chromatographic influenza vaccine].
    Bichurina MA; Goriunova VV; Zhebrun AB; Chubarova NI
    Tr Inst Im Pastera; 1979; 52():121-8. PubMed ID: 121646
    [No Abstract]   [Full Text] [Related]  

  • 6. [Improved methods of controlling the purity and activity of inactivated influenza vaccines].
    Noskov FS; Bichurina MA; Zhebrun AB; Polianskaia NIu; Kaplun IIa
    Vopr Virusol; 1985; 30(4):409-13. PubMed ID: 3933181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Possibility of preparing inactivated influenza vaccine by a combination of gel chromatography and ultrafiltration].
    Fridman AL; Ermolaev AI; Bichurina MA; Polianskaia NIu; Zheleznova NV
    Tr Inst Im Pastera; 1979; 52():103-7. PubMed ID: 550531
    [No Abstract]   [Full Text] [Related]  

  • 8. [Preparative isolation of myxovirus glycoproteins and the study of their immunogenic properties].
    Berezin VE; Zaĭdes VM; Mchedlishvili BV; Selimova LM; Kliushnik SIu
    Mol Gen Mikrobiol Virusol; 1985 Jul; (7):36-43. PubMed ID: 3025716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenicity of a subunit influenza vaccine in experiments on animals].
    Berezin VE; Zaĭdes VM; Isaeva ES; Zhdanov VM
    Vopr Virusol; 1985; 30(2):166-74. PubMed ID: 4002691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immune response of noninbred mice to subvirion influenza vaccines with various antigen and sorbent loads].
    Evdokimova IV; Zhukova TIa; Shapiro NI
    Zh Mikrobiol Epidemiol Immunobiol; 1985 Aug; (8):51-4. PubMed ID: 4060954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Increase in the specific activity of killed influenza vaccines by using polyene antibiotics].
    Shneĭder MA; Shtil'bans EB; Paleĭ EI; Vil'ner LM; Tereshin IM
    Antibiotiki; 1981 Jul; 26(7):532-7. PubMed ID: 7271267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of humoral immune response to influenza vaccines by BCG.
    Zykov MP; Subbotina TI
    Acta Virol; 1985 Sep; 29(5):403-9. PubMed ID: 2866694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinico-immunologic and allergologic studies with the inactivated influenza virus vaccine purified and concentrated by gradient centrifugation.
    Subbotina TI; Tenkova TV; Sidorova LV; Shpilyuk GF; Drinevsky VP; Voitsekhovskaya EM; Konstantinov VK; Sominina AA
    Acta Virol; 1988 Nov; 32(6):494-502. PubMed ID: 2906221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obtaining a lyophilized preparation of inactivated influenza vaccine].
    Goriunova VV; Bichurina MA; Gerasimov VA
    Tr Inst Im Pastera; 1979; 52():110-4. PubMed ID: 550533
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunogenic and reactogenic properties of inactivated influenza vaccine purified and concentrated by gradient centrifugation].
    Malikova EV; Safonova LS; Zueva LP; Znakova GM
    Tr Inst Im Pastera; 1982; 57():122-3. PubMed ID: 6763376
    [No Abstract]   [Full Text] [Related]  

  • 16. [Identification of the antigenic components of the host cell in isolated glycoproteins of the influenza virus].
    Rovnova ZI; Isaeva EI; Platonova AL; Rogacheva TA
    Vopr Virusol; 1988; 33(4):419-24. PubMed ID: 2461614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Testing of influenza virus vaccines--an international comparison].
    Klett G; Stäber H; Willkommen H
    Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931
    [No Abstract]   [Full Text] [Related]  

  • 18. Attenuated influenza A viruses with modified cleavage sites in hemagglutinin as live vaccines.
    Stech J
    Expert Rev Vaccines; 2008 Aug; 7(6):739-43. PubMed ID: 18665773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Host antigens in purified preparations of the influenza virus].
    Zhebrun AB; Polianskaia NIu; Noskov FS; Fridman EA
    Tr Inst Im Pastera; 1982; 59():70-81. PubMed ID: 7187572
    [No Abstract]   [Full Text] [Related]  

  • 20. [Analysis of the immunochemical purity of modern influenza vaccines].
    Zhebrun AB; Polianskaia NIu; Bichurina MA; Rozaeva NR; Fridman EA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):56-9. PubMed ID: 3799103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.